RecruitingCognitive Behavioral Therapy
Fear of Recurrence and Stopping Immunotherapy
Eligible age
21+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Sponsor: University of Pittsburgh
You may qualify if…
- ✓ Age 21 years and older
- ✓ Fluent in English
- ✓ Diagnosis of cancer and history of treatment with immunotherapy
You may not qualify if…
- ✕ Active suicidal ideation, delusions or hallucinations
Where it's recruiting
Pennsylvania
Pittsburgh
Source: ClinicalTrials.gov · NCT04761328 · last updated 2025-12-05